NCT04807127View on ClinicalTrials.gov

A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Pneumonitis, InterstitialImmunotherapyImmune-related Adverse Events
Interventions
DRUG

Immune checkpoint blockade

ICI, administered as standard-of-care treatment

DRUG

Targeted therapy

TKI, administered as standard-of-care treatment

RADIATION

Radiotherapy

RT, administered as standard-of-care treatment

Trial Locations (1)

3000

RECRUITING

Universitaire Ziekenhuizen Leuven, Leuven

All Listed Sponsors
collaborator

KU Leuven

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER